Table of Contents

company-logo

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Cogent Biosciences Dividend Announcement

• Cogent Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cogent Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cogent Biosciences Dividend History

Cogent Biosciences Dividend Yield

Cogent Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cogent Biosciences stock? Use our calculator to estimate your expected dividend yield:

Cogent Biosciences Financial Ratios

P/E ratio-4.40
PEG ratio1.10
P/B ratio3.39
ROE-70.85%
Payout ratio0.00%
Current ratio6.44
Quick ratio6.44
Cash Ratio1.83

Cogent Biosciences Dividend FAQ

Does Cogent Biosciences stock pay dividends?
Cogent Biosciences does not currently pay dividends to its shareholders.
Has Cogent Biosciences ever paid a dividend?
No, Cogent Biosciences has no a history of paying dividends to its shareholders. Cogent Biosciences is not known for its dividend payments.
Why doesn't Cogent Biosciences pay dividends?
There are several potential reasons why Cogent Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cogent Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cogent Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cogent Biosciences a dividend aristocrat?
Cogent Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cogent Biosciences a dividend king?
Cogent Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cogent Biosciences a dividend stock?
No, Cogent Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cogent Biosciences stocks?
To buy Cogent Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cogent Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.